Cecilia Camacho Hubner

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. ncbi request reprint Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome
    Cecilia Camacho-Hubner
    Department of Endocrinology, William Harvey Research Institute, John Vane Science Building, First Floor, Charterhouse Square, London EC1M 6BQ, United Kingdom
    J Clin Endocrinol Metab 91:1246-53. 2006
  2. ncbi request reprint Therapeutic applications of the insulin-like growth factors
    Martin O Savage
    Research Centre in Clinical and Molecular Endocrinology, William Harvey Research Institute, Queen Mary s School of Medicine and Dentistry, Queen Mary s, University of London, London, UK
    Growth Horm IGF Res 14:301-8. 2004
  3. ncbi request reprint Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders
    Martin O Savage
    Paediatric Endocrinology Unit, William Harvey Research Institute, St Bartholomew s Hospital and the London School of Medicine and Dentistry, London, UK
    Nat Clin Pract Endocrinol Metab 2:395-407. 2006
  4. ncbi request reprint Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
    Martin O Savage
    Endocrinology Centre, William Harvey Research Institute, Queen Mary, University of London, London, EC1M 6BQ UK
    Eur J Endocrinol 157:S33-7. 2007
  5. ncbi request reprint Insulin-like growth factor (IGF)-I gene deletion
    Cecilia Camacho-Hubner
    Paediatric Endocrinology Section, Department of Endocrinology, St Bartholomew s Hospital, London, UK
    Rev Endocr Metab Disord 3:357-61. 2002
  6. ncbi request reprint Phenotypic variability in growth hormone insensitivity
    Martin O Savage
    Department of Endocrinology, St Bartholomew s and the Royal London School of Medicine and Dentistry, London, UK
    J Pediatr Endocrinol Metab 15:1449-50. 2002
  7. ncbi request reprint A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia
    Farideh Miraki-Moud
    Department of Endocrinology, 51 53 Bartholomew Close, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 90:3819-23. 2005
  8. ncbi request reprint Isolated growth hormone deficiency
    Libia M Hernández
    Department of Endocrinology, William Harvey Research Institute, St Bartholomew s and The Royal London Hospitals, QM, University of London, London, UK
    Pituitary 10:351-7. 2007
  9. ncbi request reprint Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement
    Antonia M Brooke
    Department of Endocrinology, Harvey Research Institute, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 91:3773-9. 2006

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome
    Cecilia Camacho-Hubner
    Department of Endocrinology, William Harvey Research Institute, John Vane Science Building, First Floor, Charterhouse Square, London EC1M 6BQ, United Kingdom
    J Clin Endocrinol Metab 91:1246-53. 2006
    ..We have investigated a newly developed drug, rhIGF-I/rhIGFBP-3, a 1:1 molar complex of rhIGF-I and rhIGFBP-3...
  2. ncbi request reprint Therapeutic applications of the insulin-like growth factors
    Martin O Savage
    Research Centre in Clinical and Molecular Endocrinology, William Harvey Research Institute, Queen Mary s School of Medicine and Dentistry, Queen Mary s, University of London, London, UK
    Growth Horm IGF Res 14:301-8. 2004
    ..Improved glycaemic control has been reported in type 1 and type 2 diabetes in adults. A therapeutic trial in naïve children with GHIS is currently under way...
  3. ncbi request reprint Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders
    Martin O Savage
    Paediatric Endocrinology Unit, William Harvey Research Institute, St Bartholomew s Hospital and the London School of Medicine and Dentistry, London, UK
    Nat Clin Pract Endocrinol Metab 2:395-407. 2006
    ....
  4. ncbi request reprint Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
    Martin O Savage
    Endocrinology Centre, William Harvey Research Institute, Queen Mary, University of London, London, EC1M 6BQ UK
    Eur J Endocrinol 157:S33-7. 2007
    ..Genetic analysis for single-gene defects has made enormous contributions to understanding the physiology of growth regulation. Can this type of investigation help in predicting growth responses to GH or IGF-I therapy?..
  5. ncbi request reprint Insulin-like growth factor (IGF)-I gene deletion
    Cecilia Camacho-Hubner
    Paediatric Endocrinology Section, Department of Endocrinology, St Bartholomew s Hospital, London, UK
    Rev Endocr Metab Disord 3:357-61. 2002
  6. ncbi request reprint Phenotypic variability in growth hormone insensitivity
    Martin O Savage
    Department of Endocrinology, St Bartholomew s and the Royal London School of Medicine and Dentistry, London, UK
    J Pediatr Endocrinol Metab 15:1449-50. 2002
  7. ncbi request reprint A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia
    Farideh Miraki-Moud
    Department of Endocrinology, 51 53 Bartholomew Close, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 90:3819-23. 2005
    ..Non-islet cell tumor hypoglycemia (NICTH) results from the hypersecretion of pro-IGF-II by a large, usually mesenchymal tumor. Detection of pro-IGF-II in serum is a potential tumor marker in these patients...
  8. ncbi request reprint Isolated growth hormone deficiency
    Libia M Hernández
    Department of Endocrinology, William Harvey Research Institute, St Bartholomew s and The Royal London Hospitals, QM, University of London, London, UK
    Pituitary 10:351-7. 2007
    ..We review current studies and the clinical, biochemical, and molecular features described for different groups of affected individuals with IGHD...
  9. ncbi request reprint Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement
    Antonia M Brooke
    Department of Endocrinology, Harvey Research Institute, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 91:3773-9. 2006
    ..They are profoundly androgen deficient, and dehydroepiandrosterone (DHEA) has been shown to have a beneficial effect on well-being and mood in patients with adrenal failure and possibly in hypopituitarism...